TZ 101 is our phase 3 ready, off-the-shelf medical kit comprised of fucosyltransferase enzyme VI and a small molecule product. Its purpose is to prevent and reduce the risks of various life-threatening side effects associated with standard-of-care toxic cancer therapies. These side effects include serious viral, bacterial, and fungal infections, graft-versus-host disease, hemorrhaging, and stem… Continue reading TZ101